Abstract Mycobacterium avium subspecies paratuberculosis (MAP) has been implicated in the pathogenesis of Crohn's disease (CD). The role of CD susceptibility genes in association with these microbes is not known. Sixty-two early onset paediatric CD patients and 46 controls with known MAP status were analysed for an association with 34 single nucleotide polymorphisms (SNPs) from 18 CD susceptibility genes. Functional studies on peripheral blood mononuclear cells (PBMCs) were conducted on 17 CD patients with known CD mutations to assess IL-6, IL-10, and TNF-a expression upon stimulation with MAP precipitated protein derivative (PPD) and lipopolysaccharide (LPS). In addition, surface expression of IL10R and TLR4 on resting B cells, NK cells, T cells, and monocytes was assessed. A mutation in TLR4 (rs4986790) and IL10RA (rs22291130) was significantly associated with MAP-positive CD patients compared to MAP-negative CD patients (27.6 vs. 6.1 %, p = 0.021, and 62.1 vs. 33.3 %, p = 0.024, respectively). PPD and LPS significantly increased IL-6, IL-10, and TNF-a production in PBMCs. IL-10 and TNF-a production were significantly lower in a subgroup of CD patients (5/12) with a known NOD2 mutation. Receptor for IL-10 was significantly higher expressed on NK cells (CD56low) and on NK T cells harbouring a NOD2 mutations compared to wildtype cells (p = 0.031 and 0.005, respectively). TLR4 was significantly higher expressed on NK cells (CD56high) harbouring a NOD2 mutations compared to wildtype cells (p = 0.038).
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Introduction
Crohn's disease (CD) is a multifactorial disease in which a T cell-mediated mucosal inflammation is caused by a combination of environmental triggers in genetically susceptible individuals [1] . The most researched microbe is Mycobacterium avium subspecies paratuberculosis (MAP). MAP is the cause of Johne's disease in ruminants, a disease clinically very similar to CD in humans [2] [3] [4] . However, its role in human CD remains controversial [5] [6] [7] possibly due to discrepancies in detection methodology and the influence of antibiotic therapy on the gut microflora [8] . Many of the prevalence studies have been conducted in adult populations whose gut microbiota might have been altered by long-term drug treatment. Despite these confounding factors, numerous studies and meta-analysis confirmed that CD patients have an increased risk of being positive for MAP [9] [10] [11] . We have previously reported the detection of MAP in a cohort of paediatric onset CD patients with no prior drug therapy. MAP was detected by specific PCR and culture more often in children with CD compared to control children [12, 13] . MAP may be implicated in the pathogenesis of CD, perhaps in conjunction with susceptibility genes. An association with NOD2 (nucleotide oligomerization domain 2) deficiency and reduced inflammatory response was reported in NOD2 -/-mice infected with pulmonary mycobacteria [14] . Studies with human peripheral blood mononuclear cells (PBMCs) have demonstrated that individuals homozygous for the minor allele of NOD2 rs5743293 (3020inC) had an up to 70 % defective cytokine response (TNF-a, IL-1b, and IL-10) after stimulation with M. paratuberculosis compared to PBMCs with the wildtype gene.
The recognition of Mycobacterium tuberculosis by pattern recognition receptors (PRR) is essential for the activation of both the adaptive and the innate immune response. An important component is the activation of the NFkappaB signalling pathway, which results in the transcription of proinflammatory cytokine genes and thus innate immune responses [15] . The activation of NFkappaB pathway takes place via recognition of bacterial components from cell surface receptors such as toll-like receptor (TLR) receptors and NOD2 signalling [16, 17] . Conflicting data are available for an association between TLR4 mutations and CD in humans. However, a metaanalysis of studies of the most common TLR4 mutation rs4986790 (Asp299Gly) revealed that 10 of 12 studies had increased 299Gly carrier frequency in CD patients [18] . In vitro cell culture studies and in vivo mouse experiments have shown that NOD2 and TLR are two of the nonredundant mechanisms for the detection of Mycobacterium [14, 19, 20] . Ferwerda et al. [19, 20] showed that M. tuberculosis and MAP stimulated Chinese hamster ovary (CHO) cell lines transfected with human TLR2 or TLR4. The same group has also shown up to 50 % decrease in cytokine production in TLR2 and TLR4 knockout mice models after stimulation with mycobacteria.
The function of interleukin 10 (IL-10) as a pleiotropic cytokine produced by T cells, B cells, and macrophages is well defined as an immune and anti-inflammatory regulator in both innate and cell-mediated immunity [21] . IL10 receptor alpha (IL10RA) plays an essential role in IL10-mediated immune regulation [22] . The observation that IL10 -/-mice developed spontaneous enterocolitis [23] and the implication of IL10RA in ileitis mouse models [24] have suggested that human IL10RA mutation(s) play a role in the regulation of the inflammatory response in the human gut. At least 11 single nucleotide polymorphisms (SNPs) are known on the IL10RA gene of which many are silent mutations [25] . Gasche and colleagues identified two novel IL10RA variants in humans (rs2229113 and rs3135932) and showed that carriers have a reduced sensitivity to IL-10 [26] . As well, there is reduced ability of IL-10 to inhibit lipopolysaccharide-induced TNF-alpha production in human monocytes, indicating that this variant may be a loss of function allele [26] .
Animal studies and in vitro cell culture studies have provided some insights into the role of CD susceptibility genes and microbial infection. The role of human CD susceptibility genes associated with microbial infection is largely unknown. In our study, we investigated the association between 34 SNPs and MAP infection in a paediatric CD cohort and explored association of TLR4 and IL10RA polymorphisms and cytokine expression with MAP infection in early onset paediatric CD patients.
Materials and methods

Patient cohort
A total of 116 children (62 with CD and 54 with non-IBD) were previously analysed for the presence of MAP in mucosal gut biopsies, peripheral blood mononuclear cells (PBMCs), and by culture of gut biopsies [12] . A subsequent genetic study genotyped 72 CD patients and 98 non-IBD control patients for 34 CD susceptibility SNPs present in 18 genes [27] . Thus, MAP status and genotype data were available for 62 paediatric onset CD patients and 46 non-IBD controls (Supplementary Table 1 ). Logistic regression analysis was performed on this group to test for an association between MAP infection and presence of susceptibility genotypes (Supplementary Table 1 ). All statistical analysis was performed using STATA 11. All statistical cytokine analyses were performed using GraphPad prism (version 5.0). Ethics approval for the study was obtained from the Human Ethics Committee of the Royal Children's Hospital. Informed consent was obtained from each individual parent or guardian.
Functional studies
Functional cytokine studies and cell surface receptor staining were performed on PBMCs isolated from 17 CD patients with an average age of 12.8 years (8-17.2) ( Table 1 ).
In vitro PBMC stimulation with MAP precipitated protein derivative (PPD) and lipopolysaccharide (LPS)
Peripheral blood mononuclear cells were isolated from whole blood as previously described [12] . Frozen PBMCs were thawed and re-suspended in RPMI-1640 supplemented with 5 % FCS and penicillin/streptomycin. Half a million PBMCs were stimulated with PPD (1:200 dilution of 0.5 mg/ml: final concentration) or LPS (100 ng/ml) for 20 h at 37°C, 5 % CO 2 , 95 % humidity. The culture supernatants were collected and stored at -70°C for later cytokine ELISA. PPD was prepared from MAP cultures at the CSIRO Australian Animal Health Laboratory as described by Wynne et al. [28] .
Cytokine ELISA
The culture supernatants were assayed for TNF, IL-6, and IL-10 using a commercial ELISA (BD Biosciences) according to the manufacturer's specifications. Assay's limit of detection was 8 pg/ml.
Flow cytometry of TLR4 and IL10R expression TLR4 and IL-10 expression were performed on PBMC using flow cytometry. PBMCs were stained with the following anti-human monoclonal antibodies: anti-CD14 APC Cy7, anti-CD3 (Pacific Blue), anti-CD56 APC, anti-CD19 PE Cy7 (BD Biosciences), anti-TLR4 PE (eBioscience), and anti-IL10R (CDw210) PE (BD Pharmingen). CD14-positive monocytes (n = 10,000) were acquired on a FACS Canto (BD Bioscience), and FlowJo software (Tree Star) was used for analysis, and the geometric mean fluorescence of each sample was normalized to its own isotype-matched control.
Results
MAP: genotype interaction
The potential association of MAP and SNP genotypes was analysed for 62 CD patients and 46 non-IBD controls (Supplementary Table 1 ). The proportion of wildtype alleles of each of the 34 SNPs was stratified with MAP status (positive and negative) in the CD group. Linkage between TLR4 mutation (rs4986790) and IL10RA mutation (rs2229113) and the presence of MAP infection was detected in a significant subgroup of patients. Both wildtype alleles of SNPs rs2229113 and rs4986790 were significantly more often detected in MAP-negative patients compared to MAP-positive patients (66.7 vs. 37.9 %, OR = 3.27, 95 % CI 1.15-9.28, p = 0.024, and 93.9 % vs. 72.4 %, OR = 5.90, 95 % CI 1.14-30.61, p = 0.021, respectively) (Fig. 1a) . The very conservative Bonferroni correction would have generated no significant association.
In the non-IBD control group, no statistically significant associations were detected between MAP-positive and MAP-negative individuals (Supplementary Table 1 ). Manual interaction analysis of minor allelic SNPs rs2229113 (IL10RA) and rs4986790 (TLR4) revealed that both minor allelic SNPs were detected in combination more often in MAP-positive patients compared to the same SNP variant at the individual levels (82.8 vs. 62.1 % and 27.6 %, respectively). The difference between MAP-positive and MAP-negative CD patients carrying a combination of minor allelic IL10RA SNP rs2229113 and TLR4 SNP rs4986760 was highly significant (p \ 0.001, OR = 7.39, 95 % CI 2.25-24.27) (Fig. 1b) . Both SNP variants remained significantly associated with MAP infection after adjustment by logistic regression (Fig. 1b) .
Logistic regression analysis was performed to analyse SNP-SNP interaction and MAP infection between IL10RA rs2229113 variant and TLR4 rs4986790 variant within and with all other SNPs included in the previous genotype study. Logistic regression analysis of TLR4 SNP rs4986790 with all other SNPs revealed that all interactions were not significant. Logistic regression analysis was significant for Fig. 1 Stratification of TLR4 and IL10RA mutations with MAP infection in CD patients. a Associated toll-like receptor 4 (TLR4) and interleukin 10 receptor A (IL10RA) mutations with Mycobacterium avium subspecies paratuberculosis (MAP) infection in paediatric Crohn's disease (CD) patients. The proportion of positive CD patients harbouring either a TLR4 mutation (SNP variant rs4986790) and/or IL10RA mutation (SNP variant rs229133) was determined and compared to MAP-negative CD patients. Statistical analysis was conducted using Fisher's exact tests in GraphPad Prism (version 5.0d). b Logistic regression was used to determine the odds ratio and 95 % confidence interval for the association of IL10RA and TLR4 mutations in CD patients and adjusted for either mutation. Logistic regression was done in Stata (version 11.0) one MAP-SNP-SNP interaction involving IL10RA SNPs rs2229113 and IL23R SNPs rs7517847 (p = 0.042, OR = 9.55, 95 % CI 1.08-84.21). Due to the large confidence interval and not passing Bonferroni correction (p = 0.0014), this combination was not considered significant.
In our previous study, we cultured MAP from biopsy tissue from CD patients [12] . All four patients from whom MAP was cultured contained a mutation in one of the MAP-associated genes, either IL10RA or TLR4 (Table 2) . In contrast, only one of the six MAP culture-negative patients had a MAP-associated mutation; however, the same patient was MAP positive in the biopsy sample.
Expression of IL-6, IL-10, and TNF Peripheral blood mononuclear cells from 17 CD patients harbouring a range of mutations including NOD2 variants, TLR4 variants, and IL10RA variants were stimulated with PPD, LPS, and combined PPD ? LPS. Cytokine production for IL-6, IL-10, and TNF-a, regardless of mutation status, was 3.7-, 3.1-, and 2.3-fold higher upon stimulation with PPD compared to un-stimulated PBMCs (Fig. 2) . The same cytokines were 5.1-, 7.2-, and 8.4-fold higher upon LPS stimulation compared to un-stimulated PBMCs (Fig. 2) . IL-10 and TNF-a expression were significantly higher upon stimulation with LPS compared to PPD (Fig. 2) . No significant changes in IL-6, IL-10, and TNF-a production were detected between PBMCs harbouring a mutation in NOD2 and TLR4 and/or IL10RA compared to PBMCs with the wildtype form of the genes (Supplementary Fig. 1a-f) .
Adjustment for MAP infection revealed no significant changes in IL-6, IL-10, and TNF-a production between PBMCs from MAP-positive CD patients compared to MAPnegative CD patients ( Supplementary Fig. 1g-i) . We further analysed each patient individually for the effect of polymorphisms in 34 SNP variants by comparing IL-6, IL-10, and TNF-a production upon stimulation with PPD, LPS, and PPD ? LPS. The 34 SNP variants were located on 19 genes including, NOD2 (n = 4 SNPs),
, MYO9B (n = 3 SNPs), DLG5 (n = 6 SNPs). Primary adjustment was conducted with NOD2 mutations versus NOD2 wildtype alleles (Fig. 3) . In a subgroup of CD patients (5/12) with at least one mutation in the L2 ± L4 = colonic disease with or without GI involvement L3 ± L4 = ileal/colonic disease with or without GI involvement L4 = upper GI disease B1 ± P = inflammatory appearance with or without perininal (P) disease B2 ± P = stricturing disease with or without P disease B3 ± P = penetrating disease with or without P disease main NOD2 allele, cytokine expression for IL-10 and TNF-a was significantly lower compared to the remaining seven NOD2-positive patients (p \ 0.01) (Fig. 3) . Similar results were obtained between the same subgroup for IL-6 expression but the differences did not reach statistical significance (p = 0.07) (Fig. 3) . Analysis of the NOD2 gene variants revealed a distinct subgroup with significant lower cytokine expression, where the subgroup had a significant reduction in IL-6 and TNF production when compared to the NOD2 wildtype patients (Fig. 3) . This was not observed with any of the other genes (data not shown). None of 34 individual SNP variants could be specifically associated with the low cytokine expressing subgroup (CD patients 1-5, data not shown). Also, the MAP status of the low cytokine expressing subgroup (patients 1-5 Fig. 3 ) was not significantly different from the seven high cytokine expressing subgroup (patients 6-12 Fig. 3 ) or to MAP status of the NOD2 wildtype group (Fig. 3) .
IL10 receptor and TLR4 receptor expression
Basal IL10R and TLR4 protein expression was assessed on the surface of B cells, NK cells (CD56 high), NK cell (CD56 low), NK T cells, T cells, and monocytes. Both receptors were chosen because their two mutated forms were identified significantly more often in MAP-positive CD patients compared to MAP-negative CD patients. Adjustment for NOD2 mutation revealed a significantly higher level of IL10R expression in NK cell (CD56 low) (p = 0.031) and in NK T cells (p = 0.005) and a significantly higher level of TLR4 expression in NK cell (CD56 high) (p = 0.038) harbouring at least one main NOD2 mutation (Fig. 4) . No significant differences in IL10R and TLR4 expression were observed between patients with or without TLR4 and/or IL10RA mutations and between MAPpositive and MAP-negative patients (data not shown).
Discussion
In this study, we explored whether the presence of MAP was associated with any of 34 SNP variants present on 19 CD susceptibility genes in a paediatric CD cohort. The expression levels of three common cytokines were then analysed in the context of MAP and mutation status in these paediatric CD patients. This study demonstrated an association between the presence of MAP and mutations in TLR4 (rs4986790 Asp299Gly) and IL10RA (rs2229113 Gly330Arg) in paediatric CD. A synergistic interaction between the MAP-associated genetic variants was observed, with an increase in odds ratio from 3.27 to 6.05, and 5.9 to 13.14 if IL10RA mutation was adjusted for TLR4, and TLR4 mutation was adjusted for IL10RA, respectively. The importance of TLR4 and IL-10 dependency was reported by Ronni et al. [29] previously, who revealed that functional TLR4 is required in macrophages for activation of anti-inflammatory IL-10 promoters. TLR4 also plays a central role in bacterial LPS signal transduction by activation of multiple pathways including the anti-inflammatory IL-10 genes [29] . The IL10RA Gly330Arg polymorphism was associated with reduced sensitivity of IL-10 and consequently reduced inhibition of TNF-a production [26] . In our previous study, the IL10RA Gly330Arg polymorphism was not associated with CD [27] ; however, in other studies, nonsynonymous polymorphisms in IL10RA were detected more frequently in adult and paediatric CD adult patients compared to controls [26, 27] . Thus, IL10RA mutations alone are not necessarily implicated in CD but may be associated with specific microbial infections.
Mutations in TLR1, TLR2, and TLR4 genes can alter the ability to recognize pathogen-associated molecular patterns (PAMPs) [30] . The important role of TLR4 Asp299Gly polymorphism in human disease was reported Fig. 3 Single patient analysis for NOD2 mutation, MAP infection and TLR4 and IL10RA mutation. Cytokine production by PBMCs collected from paediatric CD patients adjusted for main NOD2 mutations, MAP infection, TLR4 mutation, and IL10RA mutation. The fold change for IL-6 expression (Fig. 3a) , IL-10 expression (Fig. 3b) , and TNF-a expression (Fig. 3c) for each of the individual 17 CD patients is shown. PBMCs were stimulated with PPD, LPS, or combined PPD ? LPS, and the level of cytokine expression was measured by ELISA. Statistical analysis was conducted using unpaired Student's t test in GraphPad Prism (version 5.0d). Note, a group of CD patients (5/12) with a NOD2 mutation (CD Pt 1-5) showed a significantly lower IL-10 and TNF-a production and a near significantly lower IL-6 production compared to the remaining 7 CD patients with a NOD2 mutation. PBMCs peripheral blood mononuclear cells, CD Crohn's disease patients, NOD2 nucleotidebinding oligomerization domain-containing protein 2, MAP = Mycobacterium avium subspecies paratuberculosis, TLR toll-like receptor, IL10RA interleukin receptor 10A, PPD precipitated protein derivative from, LPS lipopolysaccharide in pulmonary tuberculosis patients [31, 32] , and osteomyelitis patients [33] . Similarly, this study identified an association between TLR4 mutation (Asp299Gly) and MAP infection. This association may be specific for humans, since in previous studies, neither of the human TLR4 mutations (Asp299Gly and Thr399Ile) were associated with MAP infection in sheep and cattle [30, 34] , while, TRL1 and, TLR1 and TLR2 have also been reported to be significantly associated with MAP infection in cattle and sheep [34] . The interaction of TLR and MAP infection is further supported by studies that reported changes in cytokine expression in TLR knockout mice models with and without MAP infection [19, 20] .
Our observed lack of an association between NOD2 mutations and MAP infection in paediatric CD is in concordance with Bernstein et al. [35] who did not identify any association between NOD2 variants and serological response to MAP in IBD cases. Conversely, an association has been reported between bovine NOD2 variants and MAP infection in an animal study [36] , as well as in vivo mouse studies which implicated NOD2 mutation in defective MAP recognition [37, 38] . A link between NOD2 mutations and Mycobacterium species infection is further supported by the association of NOD2 mutations, genetically and functionally, with leprosy, caused by M. leprae [39] .
In the second part of this study, we evaluated IL-6, IL-10, and TNF-a expression levels in PBMCs. Each stimulant (PPD or LPS) significantly increased the production of cytokines regardless of CD-associated mutation or MAP status, and in no instance was a statistically significant synergistic or antagonistic effect of the activation observed. [26] . However, in the same study, IL10RA receptor staining on monocytes revealed no significant differences between wildtype and mutant cells, suggesting that mutant SNP rs2229113 of the IL10RA gene stabilizes receptor expression or increase receptor expression [26] . A functional involvement of any of the 34 SNP variants including mutations in IL10RA and TLR4 genes could not be established in this study.
Previous studies have demonstrated that individuals homozygous for the minor allele of NOD2 rs5743293 (3020inC) had up to an 80 % defective cytokine response in PBMCs [19, 20] . In our study, no significant change in IL-6, IL-10, and TNF-a expression between PBMCs with NOD2 and without NOD2 mutations was identified. Although a subgroup of five NOD2-positive patients did exhibit a significant reduction in IL-6 and TNF expression, the five NOD2-positive patients did not contain any unique mutations (including 3020inC) when compared to the remaining NOD2-positive and NOD2-negative patient groups, in this study. This suggests that another genetic defect may be present in the five patients which impacts on cytokine expression.
This study showed a significantly higher level of IL10R expression in NK cells (CD56 low) and IL10R and TLR4 expression in NK T cells harbouring a NOD2 mutation. The importance of an increased IL-10 and/or TL4 receptor expression on NK cells with a NOD2 mutation in paediatric CD is unknown. The significantly higher level of TLR4 expression in NK cells (CD56high) harbouring a NOD2 mutation raises questions regarding the NOD2/TLR4 interaction. Studies have shown that NK cells express NOD2 in response to muramyl dipeptide, a peptidoglycan constituent of both Gram-positive and Gram-negative bacteria [40] . It was also shown that in mice over-expression of NOD2 could lead to increased negative regulation of the TLR2 response and protection from trinitrobenzene sulfonic acid (TNBS)-induced colitis. However, no reduction in TLR responses was observed with cells isolated from NOD2-deficient mice [41] . Kullberg et al. proposed the absence of NOD2/TLR4 cross-tolerance as the central mechanism for the implication of NOD2 mutation in CD [42] . In animal models, NOD2 is a key regulator of intestinal microbiota, as microflora in the terminal ileum is dysregulated in NOD2-deficient mice, and NOD2-deficient ileal intestinal epithelia are unable to kill bacteria efficiently [43] . It is possible that NOD2 mutations in CD may increase disease susceptibility by altering interactions between ileal microbiota and mucosal immunity; however, the exact role of NOD2 in recognition of bacteria, including MAP, remains to be elucidated.
Conclusion
Our study provided evidence that genetic variance may confer susceptibility to specific microbial pathogens implicated in CD. This is the first study, which implicates mutations in TLR4 and IL10RA with MAP infection in paediatric CD patients. No association between NOD2 mutations and MAP infection in human CD was identified in this study. However, a significantly higher expression of IL10R and TLR4 receptors in NK cell harbouring NOD2 mutations in CD individuals was identified, highlighting the complexity of the role of NOD2 in CD pathogenesis. This study suggests that CD results where a set of specific mutations predisposes an individual to disease, and subsequent infection with one or more specific microbes triggers disease onset.
